The targeted therapy bezuclastinib was safe and rapidly reduced markers of disease burden while also improving symptoms for patients with a rare blood disorder called nonadvanced system mastocytosis, according to results of the Phase II SUMMIT trial reported by researchers at The University of Texas MD Anderson Cancer Center.
Pharmacologic restraint used in 3 percent of pediatric mental health admissions
The use of pharmacologic restraints occurs in 3 percent of hospitalizations for children admitted with a primary mental health diagnosis, according to a study published online Dec. 11 in Pediatrics.
Trust issues prevent sharing of vital health and welfare data in Australia, finds study
A lack of trust between institutions in Australia is a bigger hurdle to the easy sharing of health and social welfare data than perceived state legislation obstacles—which researchers say largely don’t have a detrimental effect in Australia.
Novel menin inhibitors show promise for patients with advanced acute myeloid leukemias
Two clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated early positive results from novel therapies targeting menin for the treatment of relapsed or refractory acute leukemias with specific genetic alterations.
Landscape for acute myeloid leukemia patients evolving rapidly as research discoveries advance new treatments
The treatment landscape for acute myeloid leukemia (AML) is evolving rapidly, as research discoveries at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and other academic cancer centers advance new, more effective therapies for this aggressive blood cancer.
Revolutionizing probiotic therapy: The emergence of CRISPR-Cas engineered strains
Probiotics, defined as live microorganisms beneficial to health, have shown promise in areas like anti-inflammatory activity and brain function, etc. However, challenges remain due to variability in tolerance and colonization among species and strains. Recent advances in genome engineering, including CRISPR-Cas, have facilitated the creation of novel probiotic strains, offering potential treatments for metabolic disorders, inflammation, infections, and cancer.
New hybrid treatment forces cancer cells to starve
The combination of a drug and a protein fragment prevents the growth of blood cancer cells, a new study in mice shows.
Persons with disabilities want Braille motion back in Parley
By Millennium Reporter
THE Kitwe Association for Persons with Disabilities has urged Parliament to revisit the decision to reject a motion advocating for the inclusion of braille writing and sign language as optional subjects in schools.
This content is locked
This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.
What to know about home care services
Most older Americans want to live at home as long as they can, but finding and affording the help they need often isn’t easy. There are severe shortages of home health aides in many parts of the country. Hiring them is costly. And most middle-class people will have to pay for home care themselves if it’s needed for the long haul.
Genomic profiling offers early clues to stomach cancer development
In a breakthrough study published in Cancer Cell, researchers have decoded critical genetic factors in intestinal metaplasia patients, shedding light on early signs and prevention strategies for stomach cancer—often a “ticking time bomb” as patients experience no or only mild symptoms in the early stages.